1 Min Read
April 12 (Reuters) - Active Biotech Ab
* Reg-Active biotech: fda grants orphan drug designation for tasquinimod for the treatment of multiple myeloma Source text for Eikon: Further company coverage: (Reporting By Anna Ringstrom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.